Medtronic (MDT) Reports Strong Q4 with $36 Billion Revenue Growth
Published on · Source: finance.yahoo.com
AI Summary
Summarized by AI from the source belowMedtronic (MDT) recorded fiscal 2026 revenue of $36.36 billion, an 8.43% increase year-over-year. The company raised its quarterly dividend to $0.72, yielding approximately 3.52%, marking 49 consecutive years of increases. Trading at 14 times forward earnings, MDT demonstrates defensive value due to its non-discretionary medical procedures and a beta of 0.597. Key risks include a $185 million tariff and 230-basis-point margin compression, but underlying demographics may support long-term growth.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About Medtronic plc (MDT)
Medtronic is one of the world’s largest medical-device makers.
The Health Care sector covers pharmaceutical, biotech, device and managed-care companies.
Earlier MDT news
MDT stock page and all news →Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
Related News
Aeromexico Plans New US Flights After Washington Lifts Restrictions
Oct 19
SpaceX AI Computing Power Rental Driving Revenue Growth but Raising Costs
Oct 19
S&P 500 and Nasdaq Rise as AI Stocks Rebound Before Earnings
Oct 19
A&W (TSX:AW) Q3 Results Show Margin Squeeze Impact
Oct 18